Skip to main content

Novavax Inc 10-Q for FY2026 Q2

Novavax Inc (NVAX)

10-Q 2026-08-06 For: 2026-06-30
View Original
Added on August 06, 2026

About this 10-Q

Novavax Inc filed this 10-Q on August 6, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$56.7M
down 76.3% from $239.24M a year earlier
Net loss
$53.39M
compared with net income of $106.51M a year earlier
Diluted EPS
-$0.32
compared with $0.62 a year earlier